We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Portola Pharmaceuticals Inc | NASDAQ:PTLA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.03 | 18.00 | 18.10 | 0 | 01:00:00 |
|
|
|
|
Delaware
|
001-35935
|
20-0216859
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
270 E. Grand Avenue
|
|
|
South San Francisco
|
California
|
94080
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock
|
|
PTLA
|
|
The Nasdaq Global Select Market
|
|
|
|
Number
|
|
Description of Document
|
|
|
|
99.1
|
|
|
104
|
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
|
|
Portola Pharmaceuticals, Inc.
|
Dated: February 26, 2020
|
|
|
|
|
|
By:
|
/s/ Mike Ouimette
|
|
|
|
Mike Ouimette
|
|
|
|
Vice President and Assistant Corporate Secretary, Legal
|
1 Year Portola Pharmaceuticals Chart |
1 Month Portola Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions